Home › Products › Oncology › Inlybest 5mg Tablet
Inlybest 5mg Tablet
Salt Composition: AXITINIB
- Manufacturer: APRAZER HEALTHCARE PVT LTD
- Pack Size: 28 TABLET(s) IN A BOTTLE
- Dosage Form: TABLET
- Strength: 5MG
- Prescription Required
- Storage: Store Inlybest 5mg tablet in the original package at room temperature (20°C to 25°C). Keep it out of reach from children.
₹2340.00₹3740.63
Inclusive of all taxes
Product Introduction
Inlybest 5mg Tablet is an anticancer medication in the class of tyrosine kinase inhibitors containing axitinib as the active ingredient. It is used to treat advanced renal cell carcinoma, a form of kidney cancer that originates in the kidney cells.
Surgical procedures are not recommended during treatment with this drug owing to elevated bleeding risk. Inform your physician before undergoing any surgery or dental procedures. Seek immediate medical attention if you experience itching, vision changes, confusion, or dizziness.
This medicine may cause harm to an unborn baby. Inform your healthcare provider if you are pregnant or planning to become pregnant before starting treatment. Both men and women should use appropriate contraceptive methods during treatment and for one week after the final dose. Breastfeeding is not advised during treatment as this drug passes into breast milk and may affect the growth and development of the infant.
Report to your doctor if you develop mouth sores, weight loss, or itchy skin. This drug is not recommended for children and adolescents below 18 years of age. Contact your doctor immediately if you experience shortness of breath, chest pain, or worsening cough.
During treatment, your doctor may carry out periodic monitoring of white blood cell counts, platelets, blood sugar, electrolytes, and kidney parameters to prevent serious complications. Gastrointestinal symptoms including diarrhoea, nausea, vomiting, and constipation may develop during treatment and should be reported to your doctor promptly.
Uses
Inlybest 5mg uses are: Advanced kidney cancer
How it works
It belongs to the category of tyrosine kinase inhibitors, which interferes with the growth of blood vessels inside the cancer cells. It also acts against a protein called receptor tyrosine kinases to interrupt cell signalling, ultimately stopping the growth and spread of cancer cells.
How to Use
Your doctor will decide the dose and duration of Inlybest 5mg tablet based on the disease condition. Always take this medicine as prescribed by your doctor. The recommended starting oral dose is 5 mg twice daily. Take the tablet at the same time every day, with or without food. Do not chew, crush, or break the tablet. Swallow the whole tablet with water. If you forgot to take the tablet, simply take your next dose at the scheduled time. Do not take a double dose to make up for a forgotten dose.
Side Effects
Inlybest 5mg side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Extreme tiredness and swelling Pressure or pain in the chest, arms, back, neck or jaw Breathlessness Numbness and weakness on one side of the body Difficulty speaking or communicating verbally Headache Vision changes or dizziness Serious bleeding problems like black tarry stools, bloody cough or bloody sputum Severe stomach pain High blood pressure Common Kidney problems Dehydration Hyper-active thyroid gland Sore throat Loss of appetite Joint pain Lack of energy Weight loss Constipation Mouth sores Skin itching, redness of skin and hair loss
References
- Pfizer, [Revised on 13th Jan 2020] [Accessed on 23rd March 2023], https://www.pfizer.ca/sites/default/files/202001/INLYTA_PM_Approved_03Jan2020_E_DC.pdf
- Pfizer Labs, Electronic Medicines Compendium(EMC), [Revised on Mar 2021] [Accessed on 23rd March 2023], https://www.medicines.org.uk/emc/files/pil.4325.pdf
- Pfizer, Fact sheet, [Revised on Sep 2012] [Accessed on 23rd March 2023], https://cdn.pfizer.com/pfizercom/news/esmo/renal_cell_carcinoma_fact_sheet.pdf
- Annex I summary of Product Characteristics - European Medicines Agency. Available at: https://www.ema.europa.eu/en/documents/product-information/inlyta-epar-product-information_en.pdf (Accessed on March 25, 2023).
- Edward Chu, Cancer Chemotherapy, Langeâs Basic and Clinical Pharmacology, 14th Edition, 2018, 948-976.
Safety Advice
Pregnancy: unsafe Inlybest 5mg tablet is not recommended for pregnant women as it may cause fetal harm. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.
Lungs: Consult your doctor It is not known whether Inlybest 5mg tablet can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
Breastfeeding: unsafe It is unsafe to breastfeed during the treatment with Inlybest 5mg tablet because it may cause harm to the baby. Please consult your doctor before breastfeeding.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.